Sign in

CIK 0001412408

  • Large accelerated filer

Phreesia, Inc.

Sign in to watch
Ticker
PHR
Exchange
NYSE
Industry
Services-Business Services, NEC
FY end
Jan 31
Incorporated
DE
Entity type
Operating
Phone
+1 888-654-7473
Business address
1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803
Former names
Phreesia Inc
Open-market buys, last 90 days
$683
in 1 filing
Open-market sales, last 90 days
$67,153
in 1 filing, $67K under 10b5-1 plans

Net −$66,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-16 Linetsky David SVP, Life Sciences Sale 10b5-1 −2,011 $23.81 $48K 219,727
2025-04-16 Linetsky David SVP, Life Sciences Sale 10b5-1 −2,488 $23.66 $59K 217,239
2025-04-08 Linetsky David SVP, Life Sciences Sale −2,410 $23.46 $57K 223,272
2025-04-08 Linetsky David SVP, Life Sciences Sale −1,534 $24.48 $38K 221,738
2025-04-08 Linetsky David SVP, Life Sciences Sale −152 $23.46 $4K 9,108
2025-04-08 Linetsky David SVP, Life Sciences Sale −96 $24.48 $2K 9,012
2025-04-04 Linetsky David SVP, Life Sciences Grant or award +6,432 225,682
2025-04-04 Linetsky David SVP, Life Sciences Grant or award +536 9,260
2025-03-19 Linetsky David SVP, Life Sciences Sale −81 $27.85 $2K 8,731
2025-03-19 Linetsky David SVP, Life Sciences Sale −7 $28.31 $198 8,724
2025-03-18 Linetsky David SVP, Life Sciences Sale −39 $26.95 $1K 8,812
2025-02-13 Linetsky David SVP, Life Sciences Sale 10b5-1 −11,616 $29.70 $345K 218,135
2025-02-07 Linetsky David SVP, Life Sciences Sale 10b5-1 −300 $29.52 $9K 229,751
2025-02-05 Linetsky David SVP, Life Sciences Sale 10b5-1 −720 $29.50 $21K 230,051
2023-12-18 Linetsky David SVP, Life Sciences Sale −100 $23.15 $2K 9,904
2022-12-15 Linetsky David SVP, Life Sciences Sale −22 $34.01 $748 9,770
2022-09-15 Linetsky David SVP, Life Sciences Grant or award +1,392 $28.72 $40K 9,792
2020-02-21 Linetsky David SVP, Life Sciences Exercise or conversion +3,413 $0.73 $2K 219,250
2020-02-21 Linetsky David SVP, Life Sciences Exercise or conversion · Stock Option (Right to Buy) −3,413 0

Page 3 of 3 · 59 trades